Endothelin Blockade in Patients With Single Ventricle Physiology.

Trial Profile

Endothelin Blockade in Patients With Single Ventricle Physiology.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Feb 2015

At a glance

  • Drugs Bosentan (Primary)
  • Indications Congenital heart defects
  • Focus Pharmacodynamics
  • Acronyms Actelion 1
  • Most Recent Events

    • 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Jun 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 12 Jun 2012 Planned end date changed from 1 Dec 2011 to 1 Aug 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top